Short interest for Imunon gives investors a sense of the degree to which investors are betting on the decline of Imunon's stock. Short interest data is updated every two weeks.

Imunon Stock (NASDAQ:IMNN), Short Interest Report

Imunon

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACMR

ADIL

ALHC

ANTE

APLT

BAND

BETS

BIDU

BMBL

BYND

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CNXC

COCO

CRGE

EBAY

EDIT

FLYW

GTLS

IFBD

IMNN

INGN

IXHL

KITT

LAZR

LFST

LMND

MSTR

MVLA

NRDY

NVAX

OCEA

OGEN

PAYO

PGNY

PSNY

QRTEA

RBOT

RVLV

RXRX

SMXT

TGTX

URBN

VANI

VIPS

VTNR

VTVT

VTYX

Shares of  Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Biotech

Health Care

General

Imunon Inc (NASDAQ: IMNN) announces interim progression-free survival (PFS) and overall survival (OS) data with IMNN-001 in its Phase 1/2 OVATION 2 Study of intraperitoneal IMNN-001 in combination with neoadjuvant chemotherapy (NACT) for newly diagnosed with advanced epithelial ovarian, fallopian tube 

Imunon Highlights Early Data From Lead Program In Ovarian Cancer

Imunon Inc

WIIM

Agilon Health shares are trading higher following Q1 earnings.

Guidance

Agilon Health Sees FY24 Total Revenues $6.125B-$6.175B vs $6.5B Est. (Prior Range $6.35B-$6.365B)

Angi (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGI#NASDAQ">ANGI</a>) reported quarterly sales of $305.390 million which beat the analyst consensus estimate of $297.551 million by 2.63 percent. This is a 22.18 percent decrease over sales of $392.407 million the same period last year.

Earnings

Earnings Beats

ANGI

Angi Q1 Sales $305.390M Beat $297.551M Estimate

POWI

Power Integrations Expects Q2 Revenues To Be $105M Plus Or Minus $5M, Est $103.533M

Inception Growth Acquisition Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGTA#NASDAQ">IGTA</a>) (the "Company") announced today that it has received approval from the Nasdaq Stock Market LLC ("Nasdaq") to list its securities on the Nasdaq Capital Market. The securities will be transferred from the Nasdaq Global Market to the Nasdaq Capital Market at the opening of business on May 8, 2024. The Company's common stock, units, warrants and rights will continue to trade under the symbols "IGTA", "IGTAU", "IGTAW" and "IGTAR" respectively and trading of its securities will be unaffected by this transfer.

IGTA

Inception Growth Acquisition Limited Announces Listing Transfer From The Nasdaq Global Market To The Nasdaq Capital Market At The Opening Of Business On May 8, 2024

<ul>
<li>The S&amp;P 500 experienced a 1% increase on Monday, fueled by potential interest rate cuts.</li>
<li>S&amp;P 500 companies anticipating a 5% earnings growth from the previous year.</li>
<li>Despite previous fluctuations, the S&amp;P 500 has recovered significantly, nearing its all-time high with a year-to-date increase of 8.9%, bolstered by strong support around the $5000 mark and optimistic earnings forecasts.</li>
</ul>
The S&amp;P 500&nbsp;(ARCA:SPY) had a strong day on Monday, moving up by 1%. This increase was driven by investors feeling optimistic about a possible interest rate cut by the Federal Reserve in September.
This optimism was boosted by comments from Fed officials like John Williams and Thomas Barkin, who suggested a more supportive monetary policy might be on the horizon.
The surge wasn&rsquo;t just in one area, but was widespread, with the industrial sector, in particular, leading by also rising 1%. It shows broad confidence across different market areas, indicating a solid base for the current market growth.
Adding to this positive mood is the ongoing earnings season, where results have been better than expected. S&amp;P 500 companies are expected to see a 5% earnings growth from last year for the first quarter, the highest since the second quarter of 2022, showing that companies are doing well even with economic challenges.
The climbing market is giving investors new hope after a bumpy period. The S&amp;P 500 dropped by 5.9% from March 28th to May 19th, but since then, it has bounced back by 4.9%, thanks to strong support around the $5000 round number.
This support area was key to the recovery, and now the index is close to its all-time high of $5264. So far this year, the S&amp;P 500 has gained 8.9%. While this is good, it&#39;s still behind the 24% growth seen in 2023.
<img alt="2024-05-07_18-58-31.jpg" src="https://www.benzinga.com/files/u517520/2024-05-07_18-58-31.jpg" style="height:345px; width:624px" />
Positive earnings reports and the hope for an easier monetary policy are giving investors a promising outlook for the rest of the year.
After the closing bell on Monday, May 6, the index closed at $5180.73 trading down by 1.05%.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

S&P 500's Remarkable Recovery And Surge As Investors Buzz Over Future Prospects And Rise In Stock Performance

RIVN

Rivian CEO RJ Scaringe Tells Reuters Going To See Meaningful Reductions In The Depreciation Costs On A Per Unit Basis; Assembly Line Shutdown Had A Number Of Costs Associated Which Increased Our Cost Of Goods Sold

PowerSchool Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWSC#NYSE">PWSC</a>) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.21 by 19.05 percent. The company reported quarterly sales of $185.00 million which beat the analyst consensus estimate of $184.82 million by 0.10 percent. This is a 16.02 percent increase over sales of $159.45 million the same period last year.

Earnings Misses

PWSC

PowerSchool Holdings Q1 2024 Adj EPS $0.17 Misses $0.21 Estimate, Sales $185.00M Beat $184.82M Estimate

PCRX

Pacira BioSciences Reiterates Its FY24 Financial Guidance; Total Revenue Of $680M-$705M, Est $691.609M

United Fire Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFCS#NASDAQ">UFCS</a>) reported quarterly earnings of $0.56 per share which beat the analyst consensus estimate of $0.47 by 19.15 percent. This is a 600 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $295.999 million which beat the analyst consensus estimate of $282.300 million by 4.85 percent. This is a 10.82 percent increase over sales of $267.104 million the same period last year.

UFCS

United Fire Gr Q1 2024 Adj EPS $0.56 Beats $0.47 Estimate, Sales $295.999M Beat $282.300M Estimate

IPAR

Inter Parfums Reaffirms FY24 EPS $5.15 Vs $5.16 Est.; Net Sales $1.45B Vs $1.454B Est.

Brookdale Sees FY24 RevPAR YoY Growth 6.25%-6.75%

Danimer Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNMR#NYSE">DNMR</a>) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 27.78 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.224 million which missed the analyst consensus estimate of $11.063 million by 7.59 percent. This is a 14.27 percent decrease over sales of $11.926 million the same period last year.

DNMR

Danimer Scientific Q1 2024 GAAP EPS $(0.26) Beats $(0.31) Estimate, Sales $10.224M Miss $11.063M Estimate

Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 75 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $11.57 million which missed the analyst consensus estimate of $11.95 million by 3.15 percent. This is a 5.14 percent decrease over sales of $12.20 million the same period last year.

MCHX

Marchex Q1 Adj $(0.02), Inline, Sales $11.57M Miss $11.95M Estimate

YouTuber MrBeast is no stranger to giving away Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) vehicles as part of his videos that often feature <a href="https://www.benzinga.com/news/23/01/30647448/mrbeasts-1-001-acts-of-charity-the-gift-of-sight-and-a-new-tesla-for-1-teenager">contests, challenges, and giveaways.</a>
The latest giveaway centers on Tesla vehicles in honor of MrBeast's birthday.
What Happened: With <a href="https://www.benzinga.com/general/entertainment/23/10/35279106/youtube-giant-mrbeast-surpasses-200m-subscribers-breaks-his-own-24-hour-view-record-and-sha">over 200 million subscribers</a> on the Alphabet Inc-owned (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) YouTube, MrBeast is one of the most followed content creators.
MrBeast, also known as Jimmy Donaldson, has 29 million followers on X and 52 million followers on Instagram to go along with his 256 million subscribers on YouTube.
While videos on YouTube often feature MrBeast giving away items including Tesla vehicles, the content creator's latest contest takes place on Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) owned Instagram.
"It's my 26th birthday, so I am giving away 26 Teslas to my followers! Like and Comment on this post tagging 2 friends to enter! Make sure you're following so I can DM you if you win a Tesla!" MrBeast posted on <a href="https://www.instagram.com/mrbeast/">Instagram</a>.
MrBeast also shared on X that he was giving away the vehicles on his Instagram account.
Billionaire Elon Musk owns X. He&#8217;s also the CEO and majority shareholder of Tesla.
The official <a href="https://drive.google.com/file/d/1xhJreKe8OF6SopY2E9TUv4_ofnz-l00f/view">rules </a>for the contest say that the giveaway is open from May 7 at 12 p.m. ET to May 10 11:59 p.m. ET. Winners will be notified on May 11 and have three days to respond to the DM from MrBeast.
The grand prize in the contest is a Cybertruck valued at $120,000. Twenty-five winners will also win a Tesla Model 3 valued at $39,000. Winners have the option to accept the cash prize value of $120,000 or $39,000 respectively instead of the prize vehicle.
Rules for the contest state the giveaway is open to people aged 18 or older in the U.S. (including Washington D.C., excluding Florida, New York), Australia, Canada, Chile, France, Germany, India, Japan, Mexico, South Korea and United Kingdom.
Related Link: <a href="https://www.benzinga.com/general/24/05/38644884/mrbeast-moves-on-from-longtime-talent-agency-report-says-why-youtube-star-could-be-changing-things-u">MrBeast Moves On From Longtime Talent Agency, Report Says &#8211; Why YouTube Star Could Be Changing Things Up</a>
Why It's Important: The giveaway from MrBeast comes as the content creator expands his presence with a <a href="https://www.benzinga.com/general/entertainment/24/03/37809533/mrbeast-confirms-beast-games-on-amazon-prime-video-with-1-000-contestants-5m-prize-its-gonn">new game show </a>coming to Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) owned Prime Video.
The new show titled "Beast Games" will have over 1,000 contestants, a $5 million prize and could set several game show records.
Along with the birthday giveaway, MrBeast also used his 26th birthday to share his progression he has made on YouTube over the years. Here is how many views MrBeast has gotten each year on YouTube since he was 12.
<ul>
<li>12: 15,000</li>
<li>13: 7,000</li>
<li>14: 41,148</li>
<li>15: 125,634</li>
<li>16: 202,000</li>
<li>17: 5,482,596</li>
<li>18: 122,441,813</li>
<li>19: 464,282,517</li>
<li>20: 2,099,879,911</li>
<li>21: 3,324,451,660</li>
<li>22: 8,184,185,544</li>
<li>23: 13,265,311,414</li>
<li>24: 19,135,206,772</li>
<li>25: 32,686,259,082</li>
<li>26: Just started</li>
</ul>
"I'm grateful after all these years I still get to do what I love," MrBeast tweeted.
The results show a lesson in keeping with content creation as it took the famous YouTuber years to hit the million view plateau. The results also show that MrBeast has consistently grown his views each year outside of age 13.
Read Next: <a href="https://www.benzinga.com/general/social-media/24/03/37836042/mrbeast-vs-elon-musk-youtuber-says-x-is-not-there-for-video-yet-they-need-a-year-or-two-to-b">MrBeast Vs. Elon Musk: YouTuber Says X Is &#8216;Not There&#8217; For Video Yet, &#8216;They Need A Year Or Two To Build It Out&#8217;</a>
Image: Shutterstock

Entertainment

Social Media

AMZN

GOOG

GOOGL

TSLA

MrBeast Is Giving Away 26 Tesla Vehicles For His 26th Birthday Including A Cybertruck: Here's How You Can Win One

2024 Annual Guidance
The Company today updated its guidance for full year 2024 revenue in the range of $2.460 to $2.485 billion, and non-GAAP fully diluted earnings per share in the range of $2.75 to $2.85. This updated guidance is an increase over the prior full year 2024 revenue guidance of $2.450 to $2.475 billion, and non-GAAP fully diluted earnings per share guidance of $2.68 to $2.70.

GMED

Globus Medical Revises FY24 EPS From $2.68-$2.70 To $2.75-$2.85 Vs $2.69 Est.; Revenue From $2.45B-$2.475B To $2.46B-$2.485B Vs $2.46B Est.

California Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRC#NYSE">CRC</a>) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0.63 by 19.05 percent. The company reported quarterly sales of $454.000 million which missed the analyst consensus estimate of $483.310 million by 6.06 percent. This is a 55.66 percent decrease over sales of $1.024 billion the same period last year.

California Resources Q1 2024 Adj EPS $0.75 Beats $0.63 Estimate, Sales $454.000M Miss $483.310M Estimate

Marathon Digital Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) has outperformed the market over the past 5 years by 30.01% on an annualized basis producing an average annual return of 43.0%. Currently, Marathon Digital Holdings has a market capitalization of $5.53 billion. 
Buying $1000 In MARA: If an investor had bought $1000 of MARA stock 5 years ago, it would be worth $6,921.23 today based on a price of $20.26 for MARA at the time of writing.
<h3>Marathon Digital Holdings's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715113928_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MARA

Here's How Much $1000 Invested In Marathon Digital Holdings 5 Years Ago Would Be Worth Today

Agilon Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 200 percent. The company reported quarterly sales of $1.604 billion which met the analyst consensus estimate. This is a 41.20 percent increase over sales of $1.136 billion the same period last year.

Agilon Health Q1 2024 GAAP EPS $0.01 Beats $(0.01) Estimate, Sales $1.604B Inline

Brookdale Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.17) by 23.53 percent. The company reported quarterly sales of $782.83 million which missed the analyst consensus estimate of $783.33 million by 0.06 percent. This is a 3.93 percent increase over sales of $753.26 million the same period last year.

Brookdale Senior Living Q1 2024 GAAP EPS $(0.13) Beats $(0.17) Estimate, Sales $782.83M Miss $783.33M Estimate

IMUNON receives $1.3M from sale of its New Jersey net operating losses

Notable earnings before Thursday's open

Imunon FY Earnings Preview

Imunon GAAP EPS of -$2.16 beats by $0.07

Imunon, Inc. (IMNN) Q4 2023 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Imunon (NASDAQ:<a href="https://investorplace.com/stock-quotes/imnn-stock-quote/">IMNN</a>) just reported results for the fourth quarter of 2023.<ul><li>Imunon reported earnings per share of -52 cents. This was above the analyst estimate for EPS of -$2.30.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/03/imnn-stock-earnings-imunon-for-q4-of-2023/">IMNN Stock Earnings: Imunon Beats EPS for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

IMNN Stock Earnings: Imunon Beats EPS for Q4 2023

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Daré Bioscience (DARE – Research Report), Legend Bio...

Analysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Imunon (IMNN)

HUT, CXAI and BDRX among pre-market losers

Imunon files to withdraw registration statement

IMUNON regains compliance with Nasdaq's listing rule

AFMD

AGRX

ALLG

ARBK

AVTX

AZUL

BDRX

CAAS

CVSI

CWCO

CXAI

DARE

DLNG

DOOO

DRIO

GLASF

GRDI

GROY

GRYP

IBIO

ITRM

LEGN

OCGN

OPRX

PTPI

QBTS

TSAT

XXII

Press Releases

Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON's IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer

Independent Lab Confirms Immunogenicity and Protection with IMUNON's IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5

IMUNON Announces Leadership Change

IMUNON Files IND Application to Begin Human Testing of IMNN-101

IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024

IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses

IMUNON Reports 2023 Financial Results and Provides Business Update

IMUNON Reports Compliance with Nasdaq Listing Requirements

IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101

IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Imunon Stock (NASDAQ:IMNN), Short Interest Report

People Also Watch